Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
  1. 4 Grant or award Boyd Peter E. acquired 100,000 shares (grant or award)
  2. 4 Grant or award SVP, Chief Commercial Officer acquired 150,000 shares (grant or award)
  3. 4 Grant or award SVP, Operations acquired 110,000 shares (grant or award)
  4. 4 Grant or award Chief Innovation/Tech Officer acquired 100,000 shares (grant or award)
  5. 4 Grant or award President and CEO acquired 447,000 shares (grant or award)
  6. 4 Grant or award SVP, General Counsel acquired 150,000 shares (grant or award)
  7. 4 Grant or award SVP, Research & Development acquired 135,000 shares (grant or award)
  8. 4 Grant or award SVP, Chief Financial Officer acquired 140,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 17 · 326 filings